IKUNO NISIBUCHI

Last Updated :2024/07/03

Affiliations, Positions
Hiroshima University Hospital(Medical), Associate Professor or Lecturer
E-mail
ikunohiroshima-u.ac.jp

Basic Information

Academic Degrees

  • Hiroshima University

Educational Activity

Course in Charge

  1. 2024, Undergraduate Education, First Semester, Radiation Biology & Radiation Health Risk Sciences
  2. 2024, Undergraduate Education, Year, Systemic Disease Control
  3. 2024, Undergraduate Education, Intensive, Practice of Medicine I
  4. 2024, Undergraduate Education, Intensive, Practice of Medicine II
  5. 2024, Graduate Education (Doctoral Program) , First Semester, Clinical Practicum in Medical Physics
  6. 2024, Graduate Education (Doctoral Program) , Second Semester, Clinical Practicum in Medical Physics

Research Activities

Academic Papers

  1. Long-term results of chemoradiotherapy with elective nodal irradiation for resectable locally advanced esophageal cancer in three-dimensional planning system, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 28(3), 382-391, 202303
  2. Radiomic Analysis for Pretreatment Prediction of Recurrence Post-Radiotherapy in Cervical Squamous Cell Carcinoma Cancer, DIAGNOSTICS, 12(10), 202210
  3. Prognostic value of quantitative parameters for esophageal squamous cell carcinoma determined by preoperative FDG-PET after trimodal therapy, SURGERY, 172(2), 584-592, 202208
  4. Development of a radiomics and machine learning model for predicting occult cervical lymph node metastasis in patients with tongue cancer, ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 134(1), 93-101, 202207
  5. Clinical Outcomes of Esophagectomy and Chemoradiotherapy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma, ANTICANCER RESEARCH, 42(5), 2791-2795, 202205
  6. Temporal changes and risk factors for esophageal stenosis after salvage radiotherapy in superficial esophageal cancer following non-curative endoscopic submucosal dissection, RADIOTHERAPY AND ONCOLOGY, 166, 65-70, 202201
  7. Investigating the displacement of radio-active sources during gold-198 grain brachytherapy for hospitalized oral cancer patients, JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 14(2), 115-122, 202204
  8. Functional image guided radiation therapy planning in volumetric modulated arc therapy for patients with malignant pleural mesothelioma, ADVANCES IN RADIATION ONCOLOGY, 2(2), 183-191, 2017
  9. Combined Ventilation and Perfusion Imaging Correlates With the Dosimetric Parameters of Radiation Pneumonitis in Radiation Therapy Planning for Lung Cancer, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93(4), 778-787, 20151115
  10. Reorganization of Damaged Chromatin by the Exchange of Histone Variant H2A.Z-2., Int J Radiat Oncol Biol Phys, 89(4), 736-744, 20140715
  11. Time-Adjusted Internal Target Volume: A Novel Approach Focusing on Heterogeneity of Tumor Motion Based on 4-Dimensional Computed Tomography Imaging for Radiation Therapy Planning of Lung Cancer., INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 89(5), 1129-1137, 20140801
  12. Long-term results of definitive concurrent chemoradiotherapy for patients with esophageal submucosal cancer (T1bN0M0), INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 20(5), 897-904, 2015, 10
  13. Relationship between sentinel lymph nodes and postoperative tangential fields in early breast cancer, evaluated using SPECT/CT, JOURNAL OF RADIATION RESEARCH, 56(5), 835-840, 201509
  14. The Time Course of Dynamic Computed Tomographic Appearance of Radiation Injury to the Cirrhotic Liver Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma, PLOS ONE, 10(6), 20150611
  15. Stereotactic body radiotherapy for patients with small hepatocellular carcinoma ineligible for resection or ablation therapies, HEPATOLOGY RESEARCH, 45(4), 378-386, 201504
  16. Permeability Surface Area Product Using Perfusion Computed Tomography Is a Valuable Prognostic Factor in Glioblastomas Treated with Radiotherapy Plus Concomitant and Adjuvant Temozolomide, WORLD NEUROSURGERY, 97, 21-26, 201701
  17. Development of cystic malacia after high-dose cranial irradiation of pediatric CNS tumors in long-term follow-up, CHILDS NERVOUS SYSTEM, 33(6), 957-964, 201706
  18. Functional image guided radiation therapy planning in volumetric modulated arc therapy for patients with malignant pleural mesothelioma., Adv Radiat Oncol., 2(2), 183-191, 20170111
  19. Clinical outcomes of concurrent chemoradiotherapy with volumetric modulated arc therapy in patients with locally advanced nasopharyngeal carcinoma., Jpn J Radiol., 2017/9/8
  20. Clinical outcomes of concurrent chemoradiotherapy with volumetric modulated arc therapy in patients with locally advanced nasopharyngeal carcinoma, JAPANESE JOURNAL OF RADIOLOGY, 35(11), 673-680, 201711
  21. Evaluation of Prognostic Factors for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery, WORLD JOURNAL OF SURGERY, 42(5), 1496-1505, 201805
  22. Quantifying esophageal motion during free-breathing and breath-hold using fiducial markers in patients with early-stage esophageal cancer, PLOS ONE, 13(6), 20180611
  23. Preoperative prediction of a pathologic complete response of esophageal squamous cell carcinoma to neoadjuvant chemoradiotherapy, SURGERY, 164(1), 40-48, 201807
  24. Long-term outcome of stereotactic body radiotherapy for patients with small hepatocellular carcinoma, HEPATOLOGY RESEARCH, 48(9), 701-707, 201808
  25. Comparison of Stereotactic Body Radiation Therapy Combined With or Without Transcatheter Arterial Chemoembolization for Patients With Small Hepatocellular Carcinoma Ineligible for Resection or Ablation Therapies, TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 17, 20180701
  26. Evaluation of optimization workflow using design of experiment (DoE) for various field configurations in volumetric-modulated arc therapy, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 54, 34-41, 201810
  27. Long-term results of neoadjuvant chemoradiotherapy using cisplatin and 5-fluorouracil followed by esophagectomy for resectable, locally advanced esophageal squamous cell carcinoma, JOURNAL OF RADIATION RESEARCH, 59(5), 616-624, 201809
  28. Development of geometrically ideal dose distribution as a reference for treatment planning in VMAT using filtered back-projection method, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 57, 115-122, 201901
  29. Early Recurrence and Cancer Death After Trimodal Therapy for Esophageal Squamous Cell Carcinoma, ANTICANCER RESEARCH, 39(3), 1433-1440, 201903
  30. Concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of the cervix in a uterus didelphys with vaginal septum, JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 11(2), 180-188, 2019
  31. Clinical Significance of F-18-Fluorodeoxyglucose-Positron Emission Tomography-Positive Lymph Nodes to Outcomes of Trimodal Therapy for Esophageal Squamous Cell Carcinoma, ANNALS OF SURGICAL ONCOLOGY, 26(6), 1869-1878, 201906
  32. Two Case Reports of Chemotherapy-Induced Radiation Myositis, 45(6), 1005-1007
  33. Comparison of clinical outcome between computed tomography-based image-guided brachytherapy and two-dimensional-based brachytherapy for cervical cancer, GYNECOLOGIC ONCOLOGY REPORTS, 29, 79-82, 201908
  34. An overview of stereotactic body radiation therapy for hepatocellular carcinoma, EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 14(4), 271-279, 20200402
  35. Effect of bevacizumab against cystic components of brain tumors, CANCER MEDICINE, 8(15), 6519-6527, 201911
  36. Analysis of cardiac toxicity after definitive chemoradiotherapy for esophageal cancer using a biological dose-volume histogram, JOURNAL OF RADIATION RESEARCH, 61(2), 298-306, 202003
  37. Effectiveness of salvage radiotherapy for superficial esophageal Cancer after non-curative endoscopic resection, RADIATION ONCOLOGY, 15(1), 20200601
  38. A Single Institution's Experience of Definitive Radiotherapy Using Volumetric-modulated Arc Therapy for Hypopharyngeal Cancers, ANTICANCER RESEARCH, 40(7), 4183-4190, 202007
  39. Predictions of Pathological Features and Recurrence Based on FDG-PET Findings of Esophageal Squamous Cell Carcinoma after Trimodal Therapy, ANNALS OF SURGICAL ONCOLOGY, 27(11), 4422-4430, 202010
  40. Long-term outcomes of induction chemotherapy followed by chemoradiotherapy using volumetric-modulated arc therapy as an organ preservation approach in patients with stage IVA-B oropharyngeal or hypopharyngeal cancers, JOURNAL OF RADIATION RESEARCH, 61(4), 554-562, 202007
  41. Evaluation of optimization workflow using custom-made planning through predicted dose distribution for head and neck tumor treatment, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 80, 167-174, 202012
  42. Long-term results of definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma, JOURNAL OF RADIATION RESEARCH, 62(1), 142-148, 202101
  43. Distribution of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma After Trimodal Therapy, ANNALS OF SURGICAL ONCOLOGY, 28(3), 1798-1807, 202103
  44. T2-FLAIR Mismatch Sign and Response to Radiotherapy in Diffuse Intrinsic Pontine Glioma, PEDIATRIC NEUROSURGERY, 56(1), 1-9, 202103
  45. Evaluating Individual Radiosensitivity for the Prediction of Acute Toxicities of Chemoradiotherapy in Esophageal Cancer Patients, RADIATION RESEARCH, 195(3), 244-252, 202103
  46. Efficacy and tolerability of preoperative chemoradiotherapy with S-1 alone for locally advanced rectal cancer, JOURNAL OF RADIATION RESEARCH, 62(2), 300-308, 202103
  47. Predicting the Local Response of Esophageal Squamous Cell Carcinoma to Neoadjuvant Chemoradiotherapy by Radiomics with a Machine Learning Method Using F-18-FDG PET Images, DIAGNOSTICS, 11(6), 202106
  48. Treatment outcomes of real-time intraoral sonography-guided implantation technique of Au-198 grain brachytherapy for T1 and T2 tongue cancer, JOURNAL OF RADIATION RESEARCH, 62(5), 871-876, 202109
  49. Brachytherapy with Au-198 grains for cancer of the floor of the mouth: relationships between radiation dose and complications, ORAL RADIOLOGY, 38(1), 105-113, 202201
  50. Reirradiation Using Au-198 Grain Brachytherapy for Recurrent Oral Cancer Cases Previously Treated by Definitive Radiotherapy, ANTICANCER RESEARCH, 42(1), 293-300, 202201
  51. Potential benefits of volumetric modulated arc therapy to reduce the incidence of >= grade 2 radiation pneumonitis in radiotherapy for locally advanced non-small cell lung cancer patients, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 51(12), 1729-1735, 202112

Invited Lecture, Oral Presentation, Poster Presentation

  1. Novel simulation for dosimetry impact of diaphragm respiratory motion in 4D VMAT for esophageal cancer., Katsuta T, Kawahara D, Murakami Y, Miyoshi S, Imano N, Kubo K, Nishibuchi I, Nagata Y, ASTRO 2022(American Society for Therapeutic Radiology and Oncology 64th the Annual Meeting), 2022/10, Without Invitation, English
  2. Usefulness of the G8 screening tool in determining treatment strategies for definitive radiotherapy of esophageal cancer in the elderly., Nishibuchi I, Murakami Y, Miyoshi S, Katsuta T, Imano N, Nagata Y, ASTRO 2022(American Society for Therapeutic Radiology and Oncology 64th the Annual Meeting), 2022/10, Without Invitation, English
  3. Pain response rates after conventional radiation therapy for bone metastases assessed using international consensus pain response endpoints: A systematic review and meta-analysis of initial radiation therapy and re-irradiation., Imano N, ASTRO 2022(American Society for Therapeutic Radiology and Oncology 64th the Annual Meeting), 2022/10, Without Invitation, English
  4. A prediction model for para-aortic lymph node metastasis in cervical cancer by radiomics analysis using pre-treatment MRI images of the primary tumor., Nishibuchi I, Kawahara d, Kawamura M, Kubo K, Imano N, Takeuchi Y, Saito A, Murakami Y, Nagata Y, ASTRO 2021(American Society for Therapeutic Radiology and Oncology 63rd the Annual Meeting), 2021/10, Without Invitation, English
  5. Temporal change and risk factor of esophageal stenosis after salvage radiotherapy for superficial esophageal cancer with non-curative endoscopic submucosal dissection, Nishibuchi I, Murakami Y, Kameoka T, Ochi M, Imano N, Takeuchi Y, Takahashi I, Kimura T, Nagata Y, ASTRO 2020 (American Society for Therapeutic Radiology and Oncology 62nd the Annual Meeting), 2020/10, Without Invitation, English
  6. Long-term outcome of definitive chemoradiotherapy for resectable locally advanced esophageal cancer, Nishibuchi I, Murakami Y, Kameoka T, Ochi M, Imano N, Takeuchi Y, Takahashi I, Kimura T, Nagata Y, "European Society for Radiotherapy and Oncology meets Asia 2019 (ESTRO) ", 2019/12, Without Invitation, English
  7. Time-Adjusted Internal Target Volume (TTV) based on Four-Dimensional Computed Tomography (4D-CT) for Radiotherapy Planning of Lung Cancer, Ikuno Nishibuchi, ASTRO, 2010, Without Invitation, English
  8. The Dynamics of Histone Variant H2A.Z upon DNA Damage., Ikuno Nishibuchi, ASTRO, 2011, Without Invitation, English
  9. Reorganization of Damaged Chromatin by the Exchange of Histone Variant H2A.Z-2., Ikuno Nishibuchi, ASTRO, 2012, Without Invitation, English
  10. SUMO E3-Ligase Regulates DNA Damage-Dependent Exchange of the Histone Variant H2A.Z-2., Ikuno Nishibuchi, ASTRO, 2013, Without Invitation, English
  11. Tolerability and Outcome of Definitive Chemoradiation Therapy for Elderly Patients With Esophageal Cancer., Ikuno Nishibuchi, ASTRO, 2014, Without Invitation, English
  12. Relationship Between Sentinel Lymph Nodes and Postoperative Tangential Fields in Early Breast Cancer Evaluated by Using SPECT/CT, Wadasaki K, Nishibuchi I, ASTRO, 2015/10, Without Invitation, English
  13. A Quantitative Index for Phase Selection in Planning of Respiratory Gating Radiation Therapy for Lung Cancer, Imano N, Nishibuchi I, ASTRO, 2015/10, Without Invitation, English
  14. Treatment results of high-dose methotrexate followed by whole brain radiotherapy with or without boost irradiation for primary CNS lymphoma., Nishibuchi I, Wadasaki K., Kenjo M., Ohnishi K., Kohno R., Kawabata H, Takeuchi Y., Doi Y., Okabe T., Kimura T., Murakami Y., Nagata Y., JASTRO, 2015/11, Without Invitation, English
  15. Current status and future strategy of radiotherapy for lung cancer., Nagata Y, Kimura T., Y., Murakami Y., Nishibuchi I., Kenjo M., Okabe T., Nishio T., Saito A., JASTRO, 2015/11, Without Invitation, Japanese
  16. Interstitial brachytherapy for early stage tongue caner: An analysis of prognostic factor of regional metastasis and local recurrence., Takeuchi Y, Murakami Y., Fujita M., Kawabata H., Nishibuchi I., Doi Y., Okabe T., Kenjo M., Kimura T., Konishi M., Nagata Y., JASTRO, 2015/11, Without Invitation, Japanese
  17. Clinical features of metachronous cancer in patients with esophageal cancer treated by definitive radiation therapy., Murakami Y, Kawabata H., Takeuchi Y., Nishibuchi I.,Okabe T., Kenjo M., Kimura T., Nagata Y., JASTRO, 2015/11, Without Invitation, Japanese
  18. The incidence and location of seed migration after transperineal interstitial prostate brachytherapy with I-125 loose seeds, Nisihibuchi I, Wadasaki K, JRS, 2015/04, Without Invitation, English
  19. Salvage radiotherapy for superficial esophageal cancer after incomplete endoscopic resection, Ikuno Nishibuchi, ASTRO, 2016/09, Without Invitation, English

Awards

  1. 2012/10/29, ASTRO 54th annual meeting Resident Poster Viewing Recognition Award, ASTRO, Reorganization of Damaged Chromatin by the Exchange of Histone Variant H2A.Z-2
  2. 2015/11/20, Umegaki Award, JASTRO, Reorganization of Damaged Chromatin by the Exchange of Histone Variant H2A.Z-2.